Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.

BACKGROUND: To date only two controlled studies have been published on the effects of domiciliary oxygen treatment on survival in patients with chronic obstructive pulmonary disease (COPD) with advanced respiratory failure. The survival in such patients despite oxygen treatment remains poor. The prescription of long term oxygen therapy (LTOT) in less severe disease remains controversial. The aim of this study was to evaluate the rationale for prescribing oxygen to patients with COPD with moderate hypoxaemia. METHODS: One hundred and thirty five patients with COPD, with PaO2 7.4-8.7 kPa (56-65 mmHg) and advanced airflow limitation (mean (SD) forced expiratory volume in one second (FEV1) 0.83 (0.28) 1), were randomly allocated to a control (n = 67) and LTOT (n = 68) group. The patients were followed every three months for at least three years or until death. RESULTS: The cumulative survival rate was 88% at one year, 77% at two years, and 66% at three years. No significant differences were found in survival rates between patients treated with LTOT and controls, nor did longer oxygen use (over 15 hours per day) improve survival. Younger age, better spirometric values, and higher body mass index predicted better survival. CONCLUSIONS: Domiciliary oxygen treatment does not prolong survival in patients with COPD with moderate hypoxaemia. Airway limitation seems to determine survival in this group of patients.

[1]  T. Rochat.  Oxygénothérapie au long cours à domicile , 1998 .

[2]  R A Cowley,et al.  Randomized clinical trial of pressure-controlled inverse ration ventilation and extra corporeal CO2 removal for ARDS. , 1995, American journal of respiratory and critical care medicine.

[3]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[4]  J. Jamart,et al.  Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. , 1994, Chest.

[5]  J. Mauël.  Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. , 1994, Respiration; international review of thoracic diseases.

[6]  A. Greil,et al.  [Long-term oxygen therapy at home. Compliance with the medical prescription and observance of the daily duration of at least 15 hours]. , 1994, Revue des maladies respiratoires.

[7]  M. Manzotti,et al.  Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. , 1994, Respiration; international review of thoracic diseases.

[8]  D. Górecka,et al.  Long-term oxygen therapy in Poland. , 1993, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[9]  K. Ström.  Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. , 1993, The American review of respiratory disease.

[10]  D. Górecka,et al.  Adherence to entry criteria and one year experience of long-term oxygen therapy in Poland. , 1992, The European respiratory journal.

[11]  E. Chailleux,et al.  Facteurs pronostiques de la survie des insuffisants respiratoires obstructifs traités par oxygénothérapie à long terme. Données de l'observatoire de l'ANTADIR. , 1992 .

[12]  W. MacNee,et al.  Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. , 1991, Chest.

[13]  C. Cooper,et al.  An analysis of sequential physiologic changes in hypoxic cor pulmonale during long-term oxygen therapy. , 1991, Chest.

[14]  J. Boe,et al.  Quality assessment and predictors of survival in long-term domiciliary oxygen therapy. The Swedish Society of Chest Medicine. , 1991, The European respiratory journal.

[15]  E. Weitzenblum,et al.  Evolution of physiological variables in patients with chronic obstructive pulmonary disease before and during long-term oxygen therapy. , 1991, Respiration; international review of thoracic diseases.

[16]  D. Postma,et al.  Prognosis of chronic obstructive pulmonary disease: the Dutch experience. , 1989, The American review of respiratory disease.

[17]  N. Anthonisen.  Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. , 1989, The American review of respiratory disease.

[18]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[19]  J. Boe,et al.  A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. , 1988, The European respiratory journal.

[20]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[21]  E. Weitzenblum,et al.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[22]  F. Khaja,et al.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.

[23]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[24]  D.,et al.  Regression Models and Life-Tables , 2022 .